Product Images Gabapentin

Gabapentin is a medication that comes in the form of a 100 mg capsule. It is available only through a prescription, and the package contains 270 capsules. The medication is manufactured by Ascend Labs, LLC, located in Montvale, NJ. The packaging includes information on NDC, expiration date, lot number, and source NDC. The medication should be kept out of children's reach, and the directions for use should be followed as provided in the package insert. The medication should be stored within a temperature range of 20-26°C (63-77°F), with permitted excursions to 15-30°C (59-86°F). The medication has been repackaged by RemedyRepack Inc., Indiana, PA.*

Gabapentin is a medication in capsule form with a strength of 100mg. It is available in a quantity of 30 and can only be obtained with a prescription. The manufacturer is Ascend Labs and it has an NDC number of 70518-2614-02. The LOT number and expiration date are not available. Patients should keep this medication away from children and follow the directions provided in the package insert. The medication needs to be stored at a temperature between 20-26°C (63-77°F) with excursions permitted to 15-30°C (59-86°F) [See USP]. This specific batch was repackaged by RemedyRepack Inc. located in Indiana, PA.*

This is a package of Gabapentin capsules, which contains 100mg of medication. The package contains 30 capsules and requires a prescription. The medication is manufactured by Ascend Labs LLC in Montvale, NJ. The package should be kept away from children and the directions for use can be found in the package insert. The medication should be stored between 20-26°C (63-77°F) but can be kept between 15-30°C (59-86°F) as specified by USP. It has been repackaged by RemedyRepack Inc. in Indiana, PA.*

Gabapentin is a medication available in a 100 mg capsule form. The package contains 100 capsules and it is only available with a prescription. The package insert should be consulted for usage instructions. The medication should be stored at a temperature between 20-26°C (63-77°F). The lot number and NDC number are provided on the package. The manufacturer is Ascend Labs, LLC located in Montvale, NJ 07645. The medication was repackaged by RemedyRepack Inc., Indiana, PA 15701.*

Gabapentin is a medication that comes in the form of 100 mg capsules. It is a prescription drug, and the packaging includes a warning to keep it out of reach of children. The medication is manufactured by Ascend Labs, LLC, located in Montvale, NJ, and the lot number can be found on the packaging. The directions for use are provided in the package insert. The medication should be stored at a temperature between 20-26°C but can be exposed to 15-30°C. The medication was repackaged by RemedyRepack Inc. located in Indiana, PA, and their contact number is also provided.*

Gabapentin is a medication that comes in a capsule form, containing 100 mg per capsule. This particular product comes in a package of 60 capsules, and it is available via prescription only. The product's NDC number is 70518-2614-06, and it is manufactured by Ascend Labs LLC of Montvale, NJ. It is important to keep the medication out of reach of children. Directions for use should be found in the package insert, and the medication should be stored between 20-26°C (63-77°F); Excursions are permitted to 15-30°C (59-86°F) as per USP. Lastly, the product has been repackaged by RemedyRepack Inc. of Indiana, PA.*

Gabapentin is a medication in capsule form with a strength of 100mg. It comes in a quantity of 100 and requires a prescription from a doctor. The NDC number is 70518-2614-07, and the manufacturer is Ascend Labs located in Montvale, NJ. The expiration date and lot number are not available. Store it in a cool, dry place between 20-26°C (63-77°F), with permissible excursions to 15-30°C (59-86°F) according to USP. It is advised to keep this and all medication out of reach of children. The directions for use are located in the package insert. This medication was repackaged by RemedyRepack Inc. in Indiana, PA.*

Gabapentin is a medication available in capsule form, with a strength of 100 mg. It can only be obtained with a prescription. The capsule is provided in a quantity of one and it should be kept out of reach of children. There are directions for use in the package insert. The medication was repackaged by RemedyRepack Inc. and the original manufacturer is Ascend Labs, LLC located in Montvale, NJ. The National Drug Code (NDC) number for this medication is 70518-2614-08 and the source NDC is 67877-0222-05. The lot number and expiration date are not available. The suggested storage temperature is within the range of 20-26°C (63-77°F). In case of excursions, the permitted temperature is 15-30°C (59-86°F) [See USP].*

Gabapentin is a medication that comes in the form of a 100 mg capsule. The bottle contains 90 capsules and it is only available with a prescription. The medication was manufactured by Ascend Labs, LLC in Montvale, NJ 07645 and repackaged by Remedy Repack Inc. The NDC number for the product is 70518-2614-00 and the source NDC is 67877-0222-10. The medication should be stored at a temperature of 20-26°C (63-77°F) and should be kept away from the reach of children. For directions regarding the use of the medication, refer to the package insert. The lot number and the expiration date of the medication are not available.*

The text is describing a study with a four-week dose titration period followed by a four-week fixed dose period. The study compares the effects of a placebo to those of Gabapentin at a dose of 3600 mg/day on pain score. The text includes a baseline pain score of 10.*

The text describes a chart or graph showing the mean pain score during a pain management study. It shows four different treatments: placebo, gabapentin at 1800mg/day, and gabapentin at 2400mg/day. The study involved a titration period, where the dose was gradually increased, and a fixed dose period. The chart includes baseline data and pain scores measured at weekly intervals.*

This appears to be a table displaying the percentage of responders (patients with a reduction in pain score) in controlled PHN studies. The table shows different studies labeled as "GBP 3600", "GEBP 1800" and "GBP 2400". The highest percentage of responders appears to be 29% in one of the studies. There are also references to different treatments such as PBO. The text also includes a figure illustrating the proportion of responders in these studies.*